RecruitingNot ApplicableNCT07159061

Neurofeedback to Treat Depression - 2

Reducing Neural Perseveration Through Closed Loop Real Time fMRI Neurofeedback to Alleviate Depressive Symptoms


Sponsor

University of Pennsylvania

Enrollment

80 participants

Start Date

Nov 21, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study tests the efficacy of a new psychotherapeutic strategy for reducing negative attention bias (and therefore depression severity) in participants with MDD. This real-time fMRI neurofeedback therapy uses cloud-based pattern classification to decode a patient's attentional state and dynamically modulate task stimuli (in a closed loop) based on this state.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study tests neurofeedback — a technique where people learn to control their own brain activity in real-time using MRI feedback — as a treatment for depression. Unlike medication, neurofeedback trains the brain directly without drugs, and this trial tests whether it can reduce depressive symptoms. **You may be eligible if...** - You are between 18 and 65 years old - You have been diagnosed with Major Depressive Disorder (MDD) or Bipolar II depression - Your depression score is at least 16 on the MADRS scale (indicating significant symptoms) - You are not currently taking any psychiatric medications or receiving therapy - You can read and understand English **You may NOT be eligible if...** - You are pregnant - You have a metal implant or severe claustrophobia (MRI contraindications) - You have a neurological disorder, psychotic disorder, or active substance abuse - You are currently taking antidepressants or other psychiatric medications Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALActive Closed Loop Real Time fMRI Neurofeedback

Active neurofeedback to target neural mechanisms underlying attentional bias in participants with major depressive discover (MDD)

BEHAVIORALSham Closed Loop Real Time fMRI Neurofeedback

Sham (placebo) neurofeedback to target neural mechanisms underlying attentional bias in participants with major depressive discover (MDD)


Locations(1)

Center for Neuromodulation in Depression and Stress

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07159061


Related Trials